文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

西太平洋区域乙肝控制与消除母婴传播进展(2005-2017)

Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2019-03-01

本报告描述2005-2017年WHO西太平洋区域乙肝控制及消除乙肝病毒母婴传播的进展。期间区域及时乙肝疫苗出生剂量覆盖率从63%升至85%,乙肝疫苗第三剂覆盖率从76%升至93%;截至2017年12月,19个(53%)国家/地区及整个区域经核实达到5岁儿童乙肝表面抗原流行率<1%的目标。

要点

  • 区域及时乙肝疫苗出生剂量覆盖率从63%升至85%,第三剂从76%升至93%。
  • 截至2017年12月,19个(53%)国家/地区及整个区域达到5岁儿童HBsAg<1%目标。
  • 15个(42%)国家/地区及时出生剂量≥95%,18个(50%)第三剂≥95%。

核心结论

  • 2005-2017年西太平洋区域乙肝控制取得进展,整个区域经核实达到5岁儿童HBsAg流行率<1%的区域和全球目标。
  • 需继续实施已验证的疫苗接种策略并加强三重消除框架下的补充预防服务,以实现2030年全球乙肝消除目标。

研究设计与样本

  • 本报告为MMWR进展报告,描述2005-2017年WHO西太平洋区域乙肝控制及消除乙肝母婴传播的进展。

主要发现

  • 区域及时乙肝疫苗出生剂量覆盖率从63%升至85%,乙肝疫苗第三剂覆盖率从76%升至93%。
  • 截至2017年12月,15个(42%)国家/地区及时出生剂量覆盖率达到≥95%。
  • 截至2017年12月,18个(50%)国家/地区乙肝疫苗第三剂覆盖率达到≥95%。
  • 截至2017年12月,19个(53%)国家/地区及整个区域经核实达到5岁儿童HBsAg流行率<1%的目标。

关键数值与推荐

  • 2005年西太平洋区域设定初始目标:到2012年将5岁儿童HBsAg流行率降至<2%。
  • 2013年设定更严格目标:到2017年将5岁儿童HBsAg流行率降至<1%,及时出生剂量和第三剂覆盖率均≥95%。
  • WHO全球卫生部门战略目标:2020年5岁儿童HBsAg流行率≤1%,2030年≤0.1%。
  • 及时乙肝疫苗出生剂量定义为出生后24小时内接种。

临床怎么用

  • 维持高及时出生剂量和第三剂覆盖率以推进区域乙肝控制目标。
  • 通过三重消除框架加强补充预防服务:孕妇常规HBsAg检测、暴露新生儿及时接种乙肝免疫球蛋白、高病毒载量母亲抗病毒治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatitis B vaccine (HepB), which has been available since 1982, provides lifelong protection against hepatitis B virus (HBV) infection and the associated 20%-30% increased lifetime risk for developing cirrhosis or hepatocellular carcinoma among >95% of vaccine recipients (1). Before HepB introduction into national childhood immunization schedules, the estimated hepatitis B surface antigen (HBsAg) prevalence in the World Health Organization (WHO) Western Pacific Region (WPR)* was >8% in 1990 (2). In 2005, the WPR was the first WHO region to establish a hepatitis B control goal, with an initial target of reducing HBsAg prevalence to <2% among children aged 5 years by 2012. In 2013, the WPR set more stringent control targets to achieve by 2017, including reducing HBsAg prevalence to <1% in children aged 5 years and increasing national coverage with both timely HepB birth dose (HepB-BD) (defined as administration within 24 hours of birth) and the third HepB dose (HepB3) to ≥95% (3). All WPR countries/areas endorsed the Regional Action Plan for Viral Hepatitis in the Western Pacific Region 2016-2020 in 2015 (4) and the Regional Framework for the Triple Elimination of Mother-to-Child Transmission of human immunodeficiency virus (HIV), Hepatitis B and Syphilis in Asia and the Pacific 2018-2030 (triple elimination framework) in 2017 (5). These regional targets and strategies are aligned with program targets established by the WHO Global Health Sector Strategy on Viral Hepatitis 2016-2021 that aim to reduce HBsAg prevalence among children aged 5 years to ≤1% by 2020 and to ≤0.1% by 2030 (6). This report describes progress made to achieve hepatitis B control in the WPR and the steps taken to eliminate mother-to-child transmission (MTCT) of HBV during 2005-2017. During this period, regional timely HepB-BD and HepB3 coverage increased from 63% to 85% and from 76% to 93%, respectively. As of December 2017, 15 (42%) countries/areas achieved ≥95% timely HepB-BD coverage; 18 (50%) reached ≥95% HepB3 coverage; and 19 (53%) countries/areas as well as the region as a whole were verified to have achieved the regional and global target of <1% HBsAg prevalence among children aged 5 years. Continued implementation of proven vaccination strategies will be needed to make further progress toward WPR hepatitis B control targets. In addition to high HepB-BD and HepB3 coverage, enhanced implementation of complementary hepatitis B prevention services through the triple elimination framework, including routine HBsAg testing of pregnant women, timely administration of hepatitis B immunoglobulin to exposed newborns, and antiviral treatment of mothers with high viral loads, will be needed to achieve the global hepatitis B elimination target by 2030.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Woodring J, Pastore R, Brink A, et al. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017. MMWR Morb Mortal Wkly Rep. 2019. PMID: 30817746. doi:10.15585/mmwr.mm6808a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。